Prospera Financial Services’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-6,272
Closed -$122K 2680
2022
Q1
$122K Buy
+6,272
New +$122K 0.01% 1049